Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 6, 2013, Pages 419-424

  Lee, Mei Hui ^a   Chen, Te Li ^a,b   Lee, Yi Tzu ^a,b,c   Huang, Lei ^a   Kuo, Shu Chen ^a,b,d   Yu, Kwok Woon ^a   Hsueh, Po Ren ^e   Dou, Horng Yunn ^d   Su, Ih Jen ^d   Fung, Chang Phone ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Chutung Veterans Hospital   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acinetobacter baumannii; BlaOxA 23; Carbapenem resistance; Molecular epidemiology

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMIKACIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN; SULBACTAM; TICARCILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CONTROLLED STUDY; HOSPITAL; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; TAIWAN; TEACHING HOSPITAL;

ACINETOBACTER BAUMANNII; BLA(OXA-23); CARBAPENEM RESISTANCE; MOLECULAR EPIDEMIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOTTING, SOUTHERN; CLUSTER ANALYSIS; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS, TEACHING; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TAIWAN;

EID: 84890126531     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.08.006     Document Type: Article

References (34)

1. Chen S.J., Chao T.F., Chiang M.C., Kuo S.C., Chen L.Y., Chiang D.H., et al. Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2011, 44:209-214.
2. Chiang M.C., Kuo S.C., Chen Y.C., Lee Y.T., Chen T.L., Fung C.P. Polymerase chain reaction assay for the detection of Acinetobacter baumannii in endotracheal aspirates from patients in the intensive care unit. J Microbiol Immunol Infect 2011, 44:106-110.
3. Hsueh P.R., Liu Y.C., Yang D., Yan J.J., Wu T.L., Huang W.K., et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist 2001, 7:373-382.
4. McCracken M., DeCorby M., Fuller J., Loo V., Hoban D.J., Zhanel G.G., et al. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. J Antimicrob Chemother 2009, 64:552-555.
5. Liang Y.C., Kuo S.C., Liu C.Y., Luo B.S., Huang L.J., Lee Y.T., et al. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. J Microbiol Immunol Infect 2011, 44:358-363.
6. Lo W.T., Lin W.J., Chiueh T.S., Lee S.Y., Wang C.C., Lu J.J. Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: a study from a medical center in northern Taiwan. J Microbiol Immunol Infect 2011, 44:131-138.
7. Taiwan Nosocomial Infections Surveillance System (TNIS). [accessed 6.12]. http://www2.cdc.gov.tw/ct.asp%3fxItem%3d7773%26ctNode%3d948%26mp%3d5.
8. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
9. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
10. Lee Y.T., Fung C.P., Wang F.D., Chen C.P., Chen T.L., Cho W.L. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit. J Microbiol Immunol Infect 2012, 45:43-51.
11. Huang L.Y., Chen T.L., Lu P.L., Tsai C.A., Cho W.L., Chang F.Y., et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008, 14:1010-1019.
12. Lu P.L., Doumith M., Livermore D.M., Chen T.-P., Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 2009, 63:641-647.
13. Koh T.H., Sng L.H., Wang G.C.Y., Hsu L.Y., Zhao Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2007, 59:627-632.
14. Zhou H., Yang Q., Yu Y.S., Wei Z.Q., Li L.J. Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China. J Clin Microbiol 2007, 45:4054-4057.
15. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol 2005, 43:2241-2245.
16. Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009, 63:55-59.
17. Lin M.F., Kuo H.Y., Yeh H.W., Yang C.M., Sung C.H., Tu C.C., et al. Emergence and dissemination of bla(OXA-23)-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan. J Microbiol Immunol Infect 2011, 44:39-44.
18. Yang S.C., Chang W.J., Chang Y.H., Tsai Y.S., Yang T.P., Juan C.W., et al. Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:601-604.
19. Mugnier P.D., Poirel L., Naas T., Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010, 16:35-40.
20. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007, 13:801-806.
21. Liu Y.H., Kuo S.C., Lee Y.T., Chang I.C., Yang S.P., Chen T.L., et al. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Microbiol Immunol Infect 2012, 45:108-112.
22. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing;eighteenth informational supplement. CLSI document 2011, CLSI, Wayne, PA, M100-MS21.
23. Ejrnaes K., Sandvang D., Lundgren B., Ferry S., Holm S., Monsen T., et al. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J Clin Microbiol 2006, 44:1776-1781.
24. OxA-51-Like gene that Is Intrinsic to A. baumannii. Antimicrob Agents Chemother 2012, 56:1124-1127.
25. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
26. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
27. OxA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:2573-2580.
28. Corvec S., Poirel L., Naas T., Drugeon H., Nordmann P. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:1530-1533.
29. Jean S.S., Hsueh P.R. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 2011, 37:291-295.
30. Jean S.S., Hsueh P.R., Lee W.S., Chang H.T., Chou M.Y., Chen I.S., et al. Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005. Int J Antimicrob Agents 2009, 33:266-271.
31. Kwon K.T., Oh W.S., Song J.H., Chang H.H., Jung S.I., Kim S.W., et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother 2007, 59:525-530.
32. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007, 60:1163-1167.
33. Segal H., Garny S., Elisha B.G. Is IS(ABA-1) customized for Acinetobacter?. FEMS Microbiol Lett 2005, 243:425-429.
34. Wang X., Zong Z., Lü X. Tn2008 is a major vehicle carrying bla(OXA-23) in Acinetobacter baumannii from China. Diagn Microbiol Infect Dis 2011, 69:218-222.